Vitamin and Asthma Study

Augusta University

Status and phase: Completed; Phase 4

Conditions: Asthma

Treatments: Drug: Vitamin D

Study type: Interventional

Funder types: Other

Identifiers

NCT01447173

VDAS

Details and patient eligibility

About

The study looks at how vitamin D supplement will improve the severity of asthma and lung function as well as biomarkers in asthmatic children.

Enrollment: 10 patients

Sex: All

Ages: 7 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• History of asthma (under control)otherwise in good general health

Exclusion criteria

• Poorly controlled asthma
• Taking daily multivitamin or vitamin D supplementation
• Taking oral steroid medication
• History of bronchopulmonary dysplasia or chronic lung disease, extreme prematurity, congenital heart disease, significant renal dysfunction or primary kidney disease, endocrinologic abnormalities of calcium metabolism or parathyroid disorders

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

10 participants in 2 patient groups, including a placebo group

2000 IU vitamin D Daily

Experimental group

Treatment:

Drug: Vitamin D

400 IU Vitamin D pill

Placebo Comparator group

Treatment:

Drug: Vitamin D